Zai Lab (ZLAB) Depreciation and Depletion (2020 - 2026)
Zai Lab's (ZLAB) quarterly Depreciation and Depletion came in at $2.3 million in Q1 2026, up 15.0% year-on-year from $2.0 million in Q1 2025, and down 4.17% quarter-over-quarter from $2.4 million in Q4 2025.
Zai Lab (ZLAB) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Depreciation and Depletion across 7 years of filings, most recently posting $2.3 million for Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $2.3 million, up 15.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (up 13.25% YoY), and the FY2025 annual result was $9.1 million, up 5.81% from the prior year.
- Depreciation and Depletion came in at $2.3 million for Q1 2026 at Zai Lab, down from $2.4 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $2.5 million in Q1 2023 to a low of $1.7 million in Q2 2022.
- The 5-year median for Depreciation and Depletion is $2.1 million (2022), against an average of $2.1 million.
- Across the five-year window, Depreciation and Depletion surged 41.79% in 2022 and dropped 14.29% in 2023, its largest moves.
- Zai Lab's Depreciation and Depletion stood at $2.0 million in 2022, then advanced by 15.0% to $2.3 million in 2023, then declined by 13.04% to $2.0 million in 2024, then grew by 20.0% to $2.4 million in 2025, then dropped by 4.17% to $2.3 million in 2026.
- The last three Depreciation and Depletion figures came in at $2.3 million (Q1 2026), $2.4 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |